OneDigital Investment Advisors’s Viking Therapeutics VKTX Stock Holding History

OneDigital Investment Advisors’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$280K	Sell	8,593 -2,019	-19%	-$64.9K	﹤0.01%	1222
2025 Q4	$373K	Buy	10,612 +1,059	+11%	+$37.5K	﹤0.01%	1096
2025 Q3	$251K	Buy	+9,553	New	+$285K	﹤0.01%	1295
2025 Q1	–	Sell	-5,189	Closed	-$209K	–	1498
2024 Q4	$209K	Buy	5,189 +1,929	+59%	+$110K	﹤0.01%	1317
2024 Q3	$206K	Buy	+3,260	New	+$191K	﹤0.01%	1356
2019 Q3	–	Sell	-542	Closed	-$4K	–	1138
2019 Q2	$4K	Hold	542	–	–	﹤0.01%	1086
2019 Q1	$5K	Hold	542	–	–	﹤0.01%	994
2018 Q4	$4K	Buy	+542	New	+$6.48K	﹤0.01%	985

Other funds holding VKTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

OneDigital Investment Advisors's VKTX Position: Q1 2026 in Review

OneDigital Investment Advisors reduced its Viking Therapeutics (VKTX) stake by 19% in Q1 2026, selling an estimated $64.9K and leaving 8,593 shares worth $280K. The position accounts for ﹤0.01% of the portfolio, ranked #1222.

OneDigital Investment Advisors first reported a position in VKTX in Q4 2018 and has held it in 8 quarters since. The position peaked at $373K in Q4 2025. 410 funds tracked by Wall St. Rank hold VKTX as of Q1 2026.

OneDigital Investment Advisors held 8,593 shares of Viking Therapeutics worth $280K as of Q1 2026.
OneDigital Investment Advisors sold 2,019 Viking Therapeutics shares in Q1 2026, an estimated $64.9K.
Viking Therapeutics made up ﹤0.01% of OneDigital Investment Advisors's portfolio in Q1 2026, its #1222 holding.
OneDigital Investment Advisors first reported a position in Viking Therapeutics in Q4 2018 and has held it in 8 quarters since.
OneDigital Investment Advisors's Viking Therapeutics position peaked at $373K in Q4 2025.
410 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2026.

Based on OneDigital Investment Advisors's 13F filing for Q1 2026, filed 8 May 2026.